These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 34846640)

  • 1. The integrated multiomic diagnosis of sporadic meningiomas: a review of its clinical implications.
    Robert SM; Vetsa S; Nadar A; Vasandani S; Youngblood MW; Gorelick E; Jin L; Marianayagam N; Erson-Omay EZ; Günel M; Moliterno J
    J Neurooncol; 2022 Jan; 156(2):205-214. PubMed ID: 34846640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of meningiomas.
    Youngblood MW; Günel M
    Handb Clin Neurol; 2020; 169():101-119. PubMed ID: 32553282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and translational advances in meningiomas.
    Suppiah S; Nassiri F; Bi WL; Dunn IF; Hanemann CO; Horbinski CM; Hashizume R; James CD; Mawrin C; Noushmehr H; Perry A; Sahm F; Sloan A; Von Deimling A; Wen PY; Aldape K; Zadeh G;
    Neuro Oncol; 2019 Jan; 21(Suppl 1):i4-i17. PubMed ID: 30649490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular alterations in meningioma: prognostic and therapeutic perspectives.
    Birzu C; Peyre M; Sahm F
    Curr Opin Oncol; 2020 Nov; 32(6):613-622. PubMed ID: 32890025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic landscape of intracranial meningiomas.
    Bi WL; Abedalthagafi M; Horowitz P; Agarwalla PK; Mei Y; Aizer AA; Brewster R; Dunn GP; Al-Mefty O; Alexander BM; Santagata S; Beroukhim R; Dunn IF
    J Neurosurg; 2016 Sep; 125(3):525-35. PubMed ID: 26771848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningiomas: Overview and New Directions in Therapy.
    Wang N; Osswald M
    Semin Neurol; 2018 Feb; 38(1):112-120. PubMed ID: 29548058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Molecular Classification and Therapeutic Opportunities in Meningiomas.
    Cordova C; Kurz SC
    Curr Oncol Rep; 2020 Jul; 22(8):84. PubMed ID: 32617743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Potential of Personalized/Precision Medicine for Meningiomas].
    Yamaguchi S; Fujimura M
    No Shinkei Geka; 2022 Jan; 50(1):132-140. PubMed ID: 35169093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Landscape of Meningiomas.
    Wang JZ; Nassiri F; Mawrin C; Zadeh G
    Adv Exp Med Biol; 2023; 1416():137-158. PubMed ID: 37432625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic profile of human meningioma cell lines.
    Mei Y; Bi WL; Greenwald NF; Agar NY; Beroukhim R; Dunn GP; Dunn IF
    PLoS One; 2017; 12(5):e0178322. PubMed ID: 28552950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and Epigenomic Landscape in Meningioma.
    Bi WL; Mei Y; Agarwalla PK; Beroukhim R; Dunn IF
    Neurosurg Clin N Am; 2016 Apr; 27(2):167-79. PubMed ID: 27012381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multiomic landscape of meningiomas: a review and update.
    Wang JZ; Nassiri F; Landry AP; Patil V; Liu J; Aldape K; Gao A; Zadeh G
    J Neurooncol; 2023 Jan; 161(2):405-414. PubMed ID: 36840836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
    Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
    BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.
    Wang JZ; Patil V; Liu J; Dogan H; Tabatabai G; Yefet LS; Behling F; Hoffman E; Bunda S; Yakubov R; Kaloti R; Brandner S; Gao A; Cohen-Gadol A; Barnholtz-Sloan J; Skardelly M; Tatagiba M; Raleigh DR; Sahm F; Boutros PC; Aldape K; ; Nassiri F; Zadeh G
    Acta Neuropathol; 2023 Jul; 146(1):145-162. PubMed ID: 37093270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
    Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
    Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of meningioma molecular subgroup and tumor recurrence.
    Youngblood MW; Miyagishima DF; Jin L; Gupte T; Li C; Duran D; Montejo JD; Zhao A; Sheth A; Tyrtova E; Özduman K; Iacoangeli F; Peyre M; Boetto J; Pease M; Avşar T; Huttner A; Bilguvar K; Kilic T; Pamir MN; Amankulor N; Kalamarides M; Erson-Omay EZ; Günel M; Moliterno J
    Neuro Oncol; 2021 May; 23(5):783-794. PubMed ID: 33068421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A current review of spinal meningiomas: epidemiology, clinical presentation and management.
    Elsamadicy AA; Reeves BC; Craft S; Sherman JJZ; Koo AB; Sayeed S; Sarkozy M; Kolb L; Lo SL; Shin JH; Sciubba DM; Mendel E
    J Neurooncol; 2023 Jan; 161(2):395-404. PubMed ID: 36637710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational patterns and regulatory networks in epigenetic subgroups of meningioma.
    Paramasivam N; Hübschmann D; Toprak UH; Ishaque N; Neidert M; Schrimpf D; Stichel D; Reuss D; Sievers P; Reinhardt A; Wefers AK; Jones DTW; Gu Z; Werner J; Uhrig S; Wirsching HG; Schick M; Bewerunge-Hudler M; Beck K; Brehmer S; Urbschat S; Seiz-Rosenhagen M; Hänggi D; Herold-Mende C; Ketter R; Eils R; Ram Z; Pfister SM; Wick W; Weller M; Grossmann R; von Deimling A; Schlesner M; Sahm F
    Acta Neuropathol; 2019 Aug; 138(2):295-308. PubMed ID: 31069492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningiomas - transition from traditional histological grading to molecular profiling in WHO CNS5: A Review.
    Goyal-Honavar A; Jayachandran R; Chacko G
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S83-S93. PubMed ID: 35562138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.